XTX Topco’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-71,040
Closed -$682K 3285
2024
Q4
$682K Sell
71,040
-111,848
-61% -$1.07M 0.06% 513
2024
Q3
$523K Buy
182,888
+58,587
+47% +$168K 0.04% 784
2024
Q2
$363K Buy
124,301
+33,651
+37% +$98.3K 0.03% 841
2024
Q1
$289K Buy
90,650
+75,984
+518% +$242K 0.04% 887
2023
Q4
$49.3K Sell
14,666
-26,116
-64% -$87.8K 0.01% 1235
2023
Q3
$97.1K Sell
40,782
-192,711
-83% -$459K 0.02% 1190
2023
Q2
$411K Buy
233,493
+82,404
+55% +$145K 0.07% 503
2023
Q1
$465K Buy
151,089
+27,053
+22% +$83.3K 0.1% 337
2022
Q4
$657K Buy
124,036
+107,856
+667% +$572K 0.14% 194
2022
Q3
$57K Buy
+16,180
New +$57K 0.01% 1011